arrow
D

Daniel Auclair

multiple myeloma res fdn
H指数:55
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

多发性骨髓瘤的综合分子谱分析可确定精细的拷贝数和表达亚型

2024-08-192
OAAI
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
2023-05-2615
PRE
Altered immune response to vaccination in patients with plasma cell premalignancy
2023-04-040
PRE
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology

Minimumm-seq: 循环肿瘤细胞的基因组测序,用于多发性骨髓瘤病理学的微创分子表征

2022-12-0710
OA
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
2022-06-0228
OAAI
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

使用获得性遗传特征,克隆性造血和端粒长度改善老年多发性骨髓瘤患者的预后分配

LEUKEMIA
IF13.4
2021-06-1910
PREAI
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins

功能基因组学鉴定介导对不同类别的癌蛋白异双功能降解物抗性的不同和重叠基因

2021-01-0168
OA
Revealing the Impact of Structural Variants in Multiple Myeloma

揭示结构变异对多发性骨髓瘤的影响

2020-11-0483
OAAI
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
2020-06-12125
OAAI
A meta-analysis of genome-wide association study and eQTL analysis of multiple myeloma among African Americans
2020-06-010
PRE
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease
LEUKEMIA
IF13.4
2020-02-1440
OAAI
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
2020-01-1419
OA
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma
2019-06-2042
OAAI